Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Capsule, delayed release	213,735 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	415,951 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	550,336 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	317,403 L.L
A02BC01	RISEK	G	Omeprazole - 20mg	20mg	Capsule, enteric coated	302,365 L.L
A02BC01	SANAMIDOL	G	Omeprazole - 20mg	20mg	Capsule	456,906 L.L
A02BC01	STOMAZOLE	G	Omeprazole - 20mg	20mg	Capsule	593,850 L.L
A02BC01	STOMAZOLE	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 40mg	40mg	Capsule, hard, gastro-resistant	503,941 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 40mg	40mg	Capsule, hard, gastro-resistant	956,816 L.L
A02BC01	OMEPRAL	G	Omeprazole - 40mg	40mg	Capsule, delayed release	499,142 L.L
A02BC01	RISEK	G	Omeprazole - 40mg	40mg	Capsule, enteric coated	522,755 L.L
A02BC01	ESELAN	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	2,073,549 L.L
A02BC01	IPPROTON	G	Omeprazole - 40mg	40mg	Injectable lyophilised powder	6,533,762 L.L
A02BC01	LOZICARE	G	Omeprazole - 40mg	40mg	Injectable powder for solution	12,446,972 L.L
A02BC01	OMEPRAZOLE ARROW	G	Omeprazole - 40mg	40mg	Injectable powder for solution	454,219 L.L
A02BC01	OMEPRAZOLE VIANEX	G	Omeprazole (sodium) - 40mg	40mg	Injectable powder for solution+diluent	467,657 L.L
A02BC01	OMEPRAZOLE-ORBUCELL	G	Omeprazole (sodium) - 40mg	40mg	Injectable solution	3,839,550 L.L
A02BC01	RISEK	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	592,635 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	895,895 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	5,916,747 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Powder for suspension	712,876 L.L
A02BC01	OMEPRAL	G	Omeprazole - 10mg	10mg	Powder for suspension	890,776 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,104,639 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	581,884 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, gastroresistant	470,345 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	771,366 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	1,381,470 L.L
A02BC02	PANTOVER	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	739,113 L.L

...

187